The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm
Open accessAbstract
Background— Marfan syndrome (MS) is a genetic disorder caused by a mutation in the fibrillin gene FBN1. Bicuspid aortic valve (BAV) is a congenital heart malformation of unknown cause. Both conditions are associated with ascending aortic aneurysm and premature death. This study examined the relationship among the secretion of extracellular matrix proteins fibrillin, fibronectin, tenascin, and vascular smooth muscle cell (VSMC) apoptosis. The role of matrix metalloproteinase (MMP)-2 in VSMC apoptosis was studied in MS aneurysm. Methods and Results— Aneurysm tissue was obtained from patients undergoing surgery (MS: 4 M, 1 F, age 27–45 years; BAV: 3 M, 2 F, age 28–65 years). Normal aorta from subjects with nonaneurysm disease was also collected (4 M, 1 F, age 23–93 years). MS and BAV aneurysm histology showed areas of cystic medial necrosis (CMN) without inflammatory infiltrate. Immunohistochemical study of cultured MS and BAV VSMC showed intracellular accumulation and reduction of extracellular distribution of fibrillin, fibronectin, and tenascin. Western blot showed no increase in expression of fibrillin, fibronectin, or tenascin in MS or BAV VSMC and increased expression of MMP-2 in MS VSMCs. There was 4-fold increase in loss of cultured VSMC incubated in serum-free medium for 24 hours in both MS (27±8%) and BAV (32±14%) compared with control (7±5%). Conclusions— In MS and BAV there is alteration in both the amount and quality of secreted proteins and an increased degree of VSMC apoptosis. Up-regulation of MMP-2 might play a role in VSMC apoptosis in MS VSMC. The findings suggest the presence of a fundamental cellular abnormality in BAV thoracic aorta, possibly of genetic origin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised diagnostic criteria for the Marfan syndrome
De Paepe, A., Devereux, R. B., Dietz, H. C., Hennekam, R. C. M., & Pyeritz, R. E. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960424)62:4<417::aid-ajmg15>3.0.co;2-r · Cited by 1,572
Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.
Sakai, L. Y., Keene, D. R., & Engvall, E. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2499 · Cited by 1,157
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms
Longo, G. M., Xiong, W., Greiner, T. C., Zhao, Y., Fiotti, N., & Baxter, B. T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215334 · Cited by 877
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1
Pereira, L., Lee, S. Y., Gayraud, B., Andrikopoulos, K., Shapiro, S. D., Bunton, T., Biery, N. J., Dietz, H. C., Sakai, L. Y., & Ramirez, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3819 · Cited by 549
Immunohistologic Abnormalities of the Microfibrillar-Fiber System in the Marfan Syndrome
Hollister, D. W., Godfrey, M., Sakai, L. Y., & Pyeritz, R. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230303 · Cited by 397
Bunton, T. E., Biery, N. J., Myers, L., Gayraud, B., Ramirez, F., & Dietz, H. C. (2001) · Circulation Research · doi:10.1161/01.res.88.1.37 · Cited by 367
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Mechanisms Underlying Aortic Dilatation in Congenital Aortic Valve Malformation
Bonderman, D., Gharehbaghi-Schnell, E., Wollenek, G., Maurer, G., Baumgartner, H., & Lang, I. M. (1999) · Circulation · doi:10.1161/01.cir.99.16.2138 · Cited by 316
Milewicz, D. M., Pyeritz, R. E., Crawford, E. S., & Byers, P. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115589 · Cited by 271
Segura, A. M., Luna, R. E., Horiba, K., Stetler‐Stevenson, W. G., McAllister, H. A., Willerson, J. T., & Ferrans, V. J. (1998) · PubMed · Cited by 218
Cited by
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
Siu, S. C., & Silversides, C. K. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.068 · Cited by 1,028
Metadata
- Authors
- Nataatmadja, M., West, M., West, J., Summers, K., Walker, P., Nagata, M., & Watanabe, T.
- Venue
- Circulation
- Published
- 2003-09-09
- Volume
- 108
- Issue
- 10_suppl_1
- Pages
- II329-34
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2006924954
- Cited by
- 354
- References
- 23
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm. https://app.cochat.ai/papers/10.1161/01.cir.0000087660.82721.15
- The paper
- Nataatmadja, M., West, M., West, J., Summers, K., Walker, P., Nagata, M., & Watanabe, T. (2003). Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm. Circulation. https://doi.org/10.1161/01.cir.0000087660.82721.15
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.